Blood eosinophils predict therapeutic effects of a GATA3-specific DNAzyme in asthma patients.
Fraunhofer Institute for Toxicology and Experimental Medicine (ITEM), Hannover, Germany.
Norbert
N
Krug
Fraunhofer Institute for Toxicology and Experimental Medicine (ITEM), Hannover, Germany.
Jens M
JM
Hohlfeld
Pulmonary Department, III. Medical Center, University Hospital Mainz, Mainz, Germany.
Roland
R
Buhl
Sterna Biologicals GmbH & Co. KG, Marburg, Germany.
Jonas
J
Renz
Institute of Laboratory Medicine, Philipps University Marburg, Marburg, Germany.
Holger
H
Garn
Institute of Laboratory Medicine, Philipps University Marburg, Marburg, Germany. Electronic address: harald.renz@uk-gm.de.
Harald
H
Renz
D001249:Asthma / Q000097:blood* / Q000175:diagnosis / Q000235:genetics / Q000628:therapy*; D015415:Biomarkers; D021881:DNA, Catalytic / Q000627:therapeutic use*; D004804:Eosinophils; D050990:GATA3 Transcription Factor / Q000235:genetics; D006801:Humans; D007958:Leukocyte Count; D011379:Prognosis
D015415:Biomarkers; D021881:DNA, Catalytic; D050990:GATA3 Transcription Factor; C494749:GATA3 protein, human